$HHSE-NEWS:..With.the.movie.TORN, Hemdale-is

New Post Public Reply Private Reply Replies (0) Message Board
HHSErocks stocksonhighalert #102854
120
$HHSE-NEWS:..With.the.movie.TORN, Hemdale-is Back.

https://deadline.com/2025/07/hemdale-back-tor...236456985/

Mike Fleming Jr: Hemdale Back From Dead With Provocative ‘Torn’;

By Mike Fleming Jr

Mike Fleming Jr
Co-Editor-in-Chief, Film

@DeadlineMike
More Stories By Mike
Mike Fleming Jr: Hemdale Back From Dead With Provocative ‘Torn’; Donald Trump’s Beak-Wetting Right Out Of ‘The Godfather Part II’
Richard Gladstein Tapped Executive Director Of Hamptons Film Festival
Langley Perer Loses Cancer Battle; Manager And Producer Was 44
View All

July 14, 2025 1:13pm
2
Comments
Services to share this page.
Share on Facebook
Post
Share to Flipboard
Email
Show more sharing options
Donald Trump and Gastone Moschin as Don Fanucci in a scene from the movie The Godfather Part II
Donald Trump and Gastone Moschin as Don Fanucci in 'The Godfather Part II'
Getty/Paramount

EXCLUSIVE: Hemdale Films, the one film production company to generate back-to-back Best Picture Oscar winners (Platoon and The Last Emperor) , is re-emerging for the first time in forever . Revived by Eric Parkinson as a releasing label, Hemdale will release Torn: The Israeli-Palestine Poster War on NYC Streets .

The provocative documentary by director Nim Shapira focuses on the street war that broke out between pro-Israel and pro-Palestinian groups that tore down each other’s messages about the 250 hostages taken by Hamas during the October 7 terror attack in Israel. The posters inflamed heated passion among those who put them up to raise awareness of the hostages and those who tore them down to show their opposition to Israel’s subsequent Gaza offensive. It led to heated arguments and often violence.

Hemdale will open the film in theaters September 5 in New York and Los Angeles with a rollout to follow in the fall and a digital release later on.

Related Stories
Donald Trump and the logo for CBS' 60 Minutes
What’s Next In The Trump-CBS, Paramount-Skydance Saga

Trump Celebrity Supporters: Famous Folks In Favor Of The 47th President
Shapira focused on 10 deeply personal stories for a film that unravels the ideological conflict and explores the limits of empathy in today’s fractured public discourse. Pic has so far had over 50 pre-release screenings across the U.S. and Canada, igniting discourse in major cities including New York, Boston, Chicago, Toronto and San Francisco.

Watch on Deadline
01:45

33:57





So how did Hemdale, the once highflying independent company started by John Daly and actor David Hemmings — best known for playing a Roman senator in Ridley Scott’s Gladiator — emerge from film history to be back in the game 30 years after becoming defunct?

First brought in to the label at the behest of owner Credit Lyonnais in 1991, Parkinson kept a candle in the window all these years for Hemdale, after the company became functionally idle following the sale of its Oscar-winning film library to MGM in 1996. Parkinson said he walked away with the Hemdale name rights, then waited for the right film to relaunch the brand as a releasing division under Hannover House, the 32-year-old independent media company .

Hemdale was started by Daly, who sold insurance, and Hemmings way back in 1967. They first managed rock bands like Black Sabbath, which coincidentally just played its final concert for the Ozzy Osbourne-fronted metal band. Hemdale financed live productions like Grease, and promoted boxing matches like the Muhammad Ali-George Foreman clash “Rumble in the Jungle.” But the true passion for Daly and Hemmings was film, and they had an enviable run.

For a while. The hits ranged from The Terminator to Hoosiers, Salvador, River’s Edge, At Close Range, Platoon, The Last Emperor and Return of the Living Dead. As is often the case with taste-making indies, money was always a problem.

I recall James Cameron once telling me that he had to find the money to end his seminal film with Linda Hamilton’s Sarah Connor and her “You’re terminated, f*cker” factory scene. Daly told Cameron he didn’t have the money for that, and to end the picture earlier, when Michael Biehn’s Kyle Reese places the explosive in the gasoline tanker driven by the cyborg played by Arnold Schwarzenegger. You wonder if that franchise would have become all that it did, had they cheap-ed out on the ending. Cameron, who earlier sold his rights to producer Gale Anne Hurd for $1 with the caveat he could not be replaced as director, would not be denied.

That predated Parkinson, who arrived on the scene in 1991 as a crisis manager planted by the French bank Credit Lyonnais to protect its investment in Hemdale and other Hollywood holdings.

“My title was President of the ‘to be formed Home Video Division,’” he recalled. “And the video division did great. We generated a lot of money. We were able to pay down the debt from $110 million to $58 million, and I attribute a lot of that to Terminator and tying in the re-release of Terminator with Terminator 2. After a period of time, Credit Lyonnais lost interest in the movie business because of the amount of money it invested, mostly in Giancarlo Parretti, and MGM. They took a lot of the companies, Orion, Dino De Laurentiis, Embassy Pictures, Hemdale, Cannon Pictures, all those companies that had loans. They rolled them all into MGM to try to make that business work. After five years there was a forced unwinding of Hemdale, and that hit John and David harder than anybody else. It had been their whole lives. I was still a young guy in my late 30s, and I made the deal that at some point in time, if I had meritorious pictures, then I would relaunch the label. The brand name was the only thing that wasn’t sold with the assets.”

He reincorporated Hemdale, and waited for the right acquisition to come along. He sparked to Torn.

“It had to be something I felt would honor the memory of John’s commitment to quality. And that’s not to say that Hannover House releases don’t have quality, but let’s be honest, some low-budget horror films aren’t going to be quite as commercially or critically meritorious as something that potentially has an Oscar nomination.”

Parkinson hopes Hemdale can become active again, not just as a distributor but as a maker of movies. They are percolating Tempus Porta, a film gearing up to shoot in Malta, and they’re attempting to work with Oliver Stone again on A Child’s Night Dream. That’s a novel Stone wrote before he served as an infantryman in Vietnam, getting wounded twice in combat and winning the Bronze Star, Purple Heart and other medals, experiences that informed his Best Picture- and Best Director-winning film Platoon. Stone’s son Sean has been pining to direct it.
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Innovent's Seven Drugs Leap onto 2026 Reimbursement Chart

Updated Category News Views 223

A Bold Move in Biopharmaceuticals Innovent Biologics just pulled a rabbit out of their hat. Seven of their cutting-edge meds made it onto China's National Reimbursement Drug List for 2026. This isn't just a spreadsheet entry—it's a lifeline thrown to patients across the oncology, metabolic, and autoimmune landscapes, as well as a financial booster for Innovent (HKEX:...

Continue Reading
LaserAway Expands to 244 Clinics Over 20 Years

Updated Category News Views 186

A Milestone in Aesthetic Dermatology Twenty years, folks. That's a long haul for most businesses, let alone one in the fickle field of aesthetic dermatology. LaserAway, the juggernaut in this arena, has just opened its 244th clinic at 6300 Kingery Hwy in Willowbrook, IL. Nothing to be sneezed at. Imagine running a business, let alone one that's been amping up aesthetic...

Continue Reading
Windward Bio Surges 68% in Nasdaq Debut

Updated Category News Views 206

Windward Bio's Impressive Nasdaq Debut Well, how's that for a debut? Windward Bio, this buzzing clinical-stage biotechnology firm, hit Nasdaq like a storm on November 13, 2026. They priced their IPO at $17.00 per share, but by market close, the stock sat comfortably at $28.50. That's a hearty 68% jump on day one, putting their market value at a sweet $1.69 billion. Behind...

Continue Reading
WeFetch AI: A New Era in Barcode Precision

Updated Category News Views 201

WeFetch AI: What's in a Name? Forget about GreenCore Solutions Corp. We're talking about WeFetch AI Corp. now. They've just changed their name, fulfilling a bureaucratic tick as of November 13, 2026. But it ain't just a name change; it's a whole new ballgame in AI-driven commerce. AI Shopping Without the Guesswork We've all been there. You think you've ordered that...

Continue Reading
Novo's CagriSema Trial Shows Promising Obesity Results

Updated Category News Views 244

Novo's Latest Weight Loss Gamble Well, look what we have here. Novo Nordisk is shaking up the obesity treatment scene with some bold numbers from their REDEFINE 9 trial. The investigational CagriSema combo of amylin analog and GLP-1 receptor agonist has churned out an eyeball-popping near 21% weight loss. For context, we're staring down the barrel of numbers far meatier...

Continue Reading
Retirement Dreams Dashed: 61% Withdraw Early

Updated Category News Views 183

Retirement Caught in the Crosshairs Just when you think the path to retirement might clear up, life slaps down older workers with economic reality. A recent LiveCareer survey underscores this financial mess, revealing that 61% of those 50 and older are raiding their own retirement funds to make ends meet. It's enough to make one's head spin. Inflation: The Unwanted Guest...

Continue Reading
EZaccessMD Data Breach: Class Action Lawsuit Looms

Updated Category News Views 0

Data breaches are the bogeyman no one wants lurking in the shadows, and when it’s your personal info at stake, folks rightfully squirm. This recent fiasco at EZaccessMD is one of those unsettling incidents. The word on the street isn't pretty: sensitive medical data has slipped through the cracks, leaving Edelson Lechtzin LLP, a heavyweight in class action maneuvers, to...

Continue Reading
BETR's Slide: Investors Face Big Losses, Leadership Shift

Updated Category News Views 84

BETR Investors Left in the Lurch It's a real trainwreck, folks. Better Home & Finance Holding Company, trading under NASDAQ:BETR, is in the spotlight for all the wrong reasons. The company expanded the class period for its investor lawsuit to include even more dates between March and August 2026, reflecting a torturous ride for shareholders. Their stock cratered by a...

Continue Reading
Beko Pushes for Policy Synergy Amidst Carbon Shakeup

Updated Category News Views 166

When big names like Beko step up on the global stage, you pay attention. During the COP31 panels in Antalya, Türkiye, the company's brass made one thing clear: we need harmony in how climate, trade, and finance policies come together. The stakes? The very strength of industrial competitiveness as new carbon rules turn the heat up on manufacturing practices. The Call for...

Continue Reading
Manhattan Associates Faces Investigation by KSF Law Firm

Updated Category News Views 203

KSF Digs Into Manhattan Associates' Claims In the swirl of the financial world, you rarely see an investigation that doesn’t raise a few eyebrows. This time, it's Manhattan Associates, Inc. (NasdaqGS: MANH) squarely in the crosshairs of Kahn Swick & Foti, LLC (KSF), a pivotal player in securities litigation. You’ve got to wonder what dirt might be uncovered here,...

Continue Reading

Top 5 Most Recently Viewed Articles

Tech Stocks Lead Strong Start for June 2024: Nvidia Tops Apple and Records Set

Updated Category Markets Views 296

Today's Monumental Achievements in the Stock Market: S&P 500 and Nasdaq 100 Hit Record Highs, Nvidia Surpasses Apple in Market Value Analyzing Today's Market Milestones Important milestones were hit in today's financial markets, that not only reflect the strength of the market, but point towards changing patterns within the tech industry. Two of the most followed indices,...

Continue Reading
Knight Therapeutics Enhances Collaboration with Helsinn for Onicit®

Updated Category News Views 218

Expansion of Knight Therapeutics and Helsinn Partnership MONTREAL and LUGANO, Switzerland – Knight Therapeutics Inc. (TSX: GUD), a pan-American specialty pharmaceutical company, has taken significant steps to enhance its partnership with Helsinn Healthcare SA, a well-respected global pharmaceutical company. This collaboration will focus on an exclusive license,...

Continue Reading
Community Preparedness Event for Houston Families: Join Us!

Updated Category News Views 149

Empowering Houstonians: A Community Event for Disaster Preparedness Whitestone Developments in collaboration with Empower CDC are taking a remarkable step to ensure families are prepared for emergencies. They are hosting a community event focused on disaster preparedness that promises to be educational and engaging. This initiative, titled "Get Ready, Houston!", aims to...

Continue Reading
Global Collaboration for Sustainable Urban Development in Focus

Updated Category News Views 207

A New Era of Sustainable Urban Development In an inspiring event held on November 1 in Bogota, a significant gathering took place centered around sustainable urban development. This thematic session was part of the 2025 Global Observance of World Cities Day, marking an important milestone in addressing environmental concerns globally. Participation and Significance of the...

Continue Reading
Geotab® Transforming Fleet Management for Government Efficiency

Updated Category News Views 47

Geotab® Enhances Fleet Management with Telematics Solutions Geotab Inc. has taken a significant step towards improving operational efficiency by partnering with the Delaware Department of Transportation (DelDOT). This collaboration aims to leverage data insights and artificial intelligence to boost efficiency and promote sustainability in governmental fleet operations....

Continue Reading